Company: AEMD
Filing Date: 2025-08-20
Form Type: S-1
Source: 0001683168-25-006352
Chunk: 48

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-20
Form: S-1
Chunk 48
---
 proceeds to us from this offering by approximately $
million, assuming the number of shares and warrants offered by us, as set forth on the cover page of this prospectus, remains the same,
after deducting the placement agent fees and estimated offering expenses payable by us. We may also increase or decrease the number of
shares of our common stock and warrants we are offering. Each 1.0 million share increase (decrease) in the number of shares sold
in this offering would increase (decrease) the expected net proceeds of the offering to us by approximately $ million,
assuming that the assumed combined public offering price per share and accompanying warrant remains the same.

We currently intend to use the
net proceeds of the Company Offering for general corporate purposes, which will include research and development expenses, clinical trial
expenses, capital expenditures and working capital. We may also use a portion of the net proceeds from the Company Offering to in-license,
acquire, or invest in complementary businesses, technologies, products or assets. However, we have no current plans, commitments or obligations
to do so. Pending use of the net proceeds, we intend to invest the proceeds in a variety of capital preservation instruments, including short-term, investment-grade, interest-bearing instruments.

We cannot currently allocate specific
percentages of the net proceeds to us from the Company Offering that we may use for the purposes specified above and our management will
have broad discretion in the allocation of the net proceeds.

| 27 |

<div align='center'>SELLING SECURITYHOLDERS</div>

This prospectus covers the resale
or other disposition by the Selling Securityholders identified in the table below of up to 1,550,000 shares of common stock issuable upon
the exercise Inducement Warrants.

We are registering the shares
of common stock underlying the Inducement Warrants in order to permit the Selling Securityholders to offer the shares of common stock
for resale from time to time. The registration of such common stock does not necessarily mean, however, that any of the shares of common
stock will be offered or sold by the Selling Securityholders. We will not receive any proceeds from the sale of the common stock by the
Selling Securityholders, and we have borne and will continue to bear the costs relating to the registration of these shares of common
stock, other than commissions and discounts of agents or broker-dealers and transfer taxes, if any.

The Inducement Warrants held by
the Selling Securityholders contain limitations which prevent the holder from exercising